On 05/16/2013, DS Healthcare Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

DS Healthcare Group, Inc. announced earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported net revenues grew to $3,965,000, a 100% increase over revenues of $1,983,982 in the first quarter of 2012. Revenue growth was primarily driven by increased sales and continued demand for the company's products, supported by its extensive marketing and sales efforts to expand the distributor and customer base. Net loss increased by 5% to $457,993 or $0.04 per basic and diluted share in the first quarter of 2013, as compared with a net loss of $440,337 or $0.04 per basic and diluted share in the first quarter of 2012.

DS Healthcare Group Inc. announced the launch of Spectral.DNC-N, the product to incorporate the proprietary Nanoxidil compound, a powerful, gentle, nondrug alternative to minoxidil. The new product is formulated to help stimulate hair across the entire scalp. It employs the Nanosome-encapsulation system -- proprietary to the company's DS Laboratories brand -- to transport ingredients deeper into follicles for more effective results. Spectral.DNC-N is the addition to the Spectral line, the first topical treatment series to address more than 20 potential causes of hair thinning and loss. Spectral products target these challenges with multiple bioactive ingredients to promote follicle rejuvenation throughout the entire scalp, as minoxidil does at the vertex. The new formula was created to surpass the results obtained from older products. The nondrug biotechnology is lightweight, easy to use, and does not leave a heavy, greasy, or unsightly residue, which is common with mass-market hair-growth products. In the hair follicle, Spectral.DNC-N generates adenosine triphosphate, the universal currency of bioenergy, and deposits a multitude of key compounds via sophisticated delivery systems. The formula is anti-inflammatory and antihormonal and delivers hydration, nutrition, stimulation, and rejuvenation. New Nanoxidil 5%, a key compound in the product, has a lower molecular weight and does not require the chemical solvents that often irritate scalp. It works well for women with noticeable thinning and for men in the early or moderate stages of thinning. It benefits users with receding hairlines or patchy eyebrows and serves as an overall preventative therapy. Lightweight and comfortable to use, Spectral.DNC-N contains procyanidin B-2 (apple polyphenol) to encourage hairline as well as vertex growth, retinol for better absorption, adenosine for cellular repair, patented Aminexil(R) to counter perifollicular fibrosis, copper peptides to fight scalp inflammation, and herbal extracts to support a healthy and comfortable overall condition.